Treatment patterns and outcomes for patients with RET-altered thyroid cancer treated with selpercatinib in Europe: Final Results from the SPRINT-RET study.

Retevmo (selpercatinib) - Eli Lilly

https://www.endocrine-abstracts.org/ea/0119/ea0119ps1-09-04

Kee Howe Wong 1; Christine Spitzweg 2; Jorge Hernando 3; Salvatore Alfieri 4; Ellen Kaptieijn 5; Manoj Khanal 6; Yuan Yuan Wang 7; Nivedita Sharma 7; Ana Sofia Afonso 7; Scott Barker 7; Montse Pedrs 8; Daniel Cuadras 8; Grace Segall 7

Sep 9, 2026